PDFF Biomarker Ctte: Difference between revisions
Jump to navigation
Jump to search
| Line 10: | Line 10: | ||
'''Approved call summaries:''' | '''Approved call summaries:''' | ||
*[[Media:2020_05-07_QIBA_PDFF_Biomarker_Cmte_Call_Summary-FINAL.pdf|May 7, 2020]] | |||
*[[Media:2019_11-07_QIBA_PDFF_Biomarker_Cmte_Call_Summary-FINAL.pdf|November 7, 2019]] | *[[Media:2019_11-07_QIBA_PDFF_Biomarker_Cmte_Call_Summary-FINAL.pdf|November 7, 2019]] | ||
*[[Media:2019_09-05_QIBA_PDFF_Biomarker_Cmte_Call_Summary-FINAL.pdf|September 5, 2019]] | *[[Media:2019_09-05_QIBA_PDFF_Biomarker_Cmte_Call_Summary-FINAL.pdf|September 5, 2019]] | ||
'''''[[PDFF Biomarker Committee Call Summaries Archive]]''''' | '''''[[PDFF Biomarker Committee Call Summaries Archive]]''''' | ||
Revision as of 14:45, 6 July 2020
- Co-chairs: Scott Reeder, MD, PhD, Takeshi Yokoo, MD, PhD
- RSNA Staff Support: Susan Stanfa
The PDFF Biomarker Committee seeks to develop a quantitative Profile for PDFF.
Meetings
Approved call summaries:
PDFF Biomarker Committee Call Summaries Archive